Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Editas Medicine (EDIT) Invested Capital: 2015-2025

Historic Invested Capital for Editas Medicine (EDIT) over the last 10 years, with Sep 2025 value amounting to $72.5 million.

  • Editas Medicine's Invested Capital fell 58.71% to $72.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $72.5 million, marking a year-over-year decrease of 58.71%. This contributed to the annual value of $191.7 million for FY2024, which is 45.08% down from last year.
  • Latest data reveals that Editas Medicine reported Invested Capital of $72.5 million as of Q3 2025, which was down 4.40% from $75.9 million recorded in Q2 2025.
  • Editas Medicine's Invested Capital's 5-year high stood at $638.0 million during Q1 2021, with a 5-year trough of $72.5 million in Q3 2025.
  • In the last 3 years, Editas Medicine's Invested Capital had a median value of $232.0 million in 2024 and averaged $235.1 million.
  • In the last 5 years, Editas Medicine's Invested Capital surged by 171.99% in 2021 and then tumbled by 67.30% in 2025.
  • Quarterly analysis of 5 years shows Editas Medicine's Invested Capital stood at $553.6 million in 2021, then plummeted by 34.85% to $360.7 million in 2022, then fell by 3.21% to $349.1 million in 2023, then tumbled by 45.08% to $191.7 million in 2024, then crashed by 58.71% to $72.5 million in 2025.
  • Its last three reported values are $72.5 million in Q3 2025, $75.9 million for Q2 2025, and $117.0 million during Q1 2025.